Karmanos Cancer Institute announces additions to Board of Directors
Karmanos treats more than 12,000 new patients annually and is Michigan's largest cancer care and research network.
- Karmanos treats more than 12,000 new patients annually and is Michigan's largest cancer care and research network.
- "We are honored to welcome these leaders to our board," said Gerold Bepler, M.D., Ph.D., president and chief executive officer of Karmanos Cancer Institute.
- This, combined with a personal connection to Karmanos, will make her a valuable addition to the board.
- Arends is passionate about eradicating cancer and has a close relative receiving care at Karmanos.